Literature DB >> 8689928

Anticoagulant pretreatment attenuates production of cytokine-induced neutrophil chemoattractant following ischemia-reperfusion of rat liver.

N Hisama1, Y Yamaguchi, K Okajima, M Uchiba, K Murakami, K Mori, S Yamada, M Ogawa.   

Abstract

We investigated whether anticoagulation would diminish ischemia-reperfusion injury of the liver. Liver ischemia was induced in rats by occluding the portal vein for 30 min. Anticoagulant was injected intravenously 10 min before occlusion. Serum concentrations of cytokine-induced neutrophil chemoattractant (CINC) in untreated rats increased following reperfusion, reaching a peak at 6 hr, then decreasing gradually to control levels by 24 hr. CINC levels in rats pretreated with heparin (50 units/kg), AT-III (250 units/kg), or DEGR-Xa (10 mg/kg) peaked at 3 hr after reperfusion and declined to baseline within 12 hr; peak CINC values were significantly lower than in untreated control rats. Expression of CINC mRNA in liver tissue paralleled the CINC serum levels. Both myeloperoxidase activity and the number of neutrophils in the liver were decreased in the anticoagulant groups. In addition, significant correlations were observed between the maximum values of AST, ALT, and LDH versus the peak CINC levels following ischemia-reperfusion. These results indicate that the release of CINC after ischemia-reperfusion of the liver is mediated by activation of coagulation within the hepatic microcirculation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8689928     DOI: 10.1007/bf02088576

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  35 in total

1.  Intracellular control of human neutrophil secretion. I. C5a-induced stimulus-specific desensitization and the effects of cytochalasin B.

Authors:  P M Henson; B Zanolari; N A Schwartzman; S R Hong
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

2.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

3.  Relationship between tissue factor expression and deposition of fibrin, platelets, and leukocytes on cultured endothelial cells under venous blood flow conditions.

Authors:  D Kirchhofer; K S Sakariassen; M Clozel; T B Tschopp; P Hadváry; Y Nemerson; H R Baumgartner
Journal:  Blood       Date:  1993-04-15       Impact factor: 22.113

4.  Proteolysis by neutrophils. Relative importance of cell-substrate contact and oxidative inactivation of proteinase inhibitors in vitro.

Authors:  E J Campbell; R M Senior; J A McDonald; D L Cox
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

Review 5.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

Authors:  M Baggiolini; A Walz; S L Kunkel
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

6.  Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat.

Authors:  J S Warren; K R Yabroff; D G Remick; S L Kunkel; S W Chensue; R G Kunkel; K J Johnson; P A Ward
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

7.  Pulmonary neutrophil kinetics after thrombin-induced intravascular coagulation.

Authors:  J A Cooper; S J Solano; R Bizios; J E Kaplan; A B Malik
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1984-09

8.  Changes in the levels of rat interleukin 8/CINC and gelatinase in the exudate of carrageenin-induced inflammation in rats.

Authors:  H Nakagawa; A Ikesue; H Kato; H Debuchi; K Watanabe; S Tsurufuji; M Naganawa; M Mitamura
Journal:  J Pharmacobiodyn       Date:  1992-09

9.  Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells.

Authors:  P Ghezzi; C A Dinarello; M Bianchi; M E Rosandich; J E Repine; C W White
Journal:  Cytokine       Date:  1991-05       Impact factor: 3.861

10.  Synthesis and release of interleukin 1 by reoxygenated human mononuclear phagocytes.

Authors:  S Koga; S Ogawa; K Kuwabara; J Brett; J A Leavy; J Ryan; Y Koga; J Plocinski; W Benjamin; D K Burns
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more
  5 in total

Review 1.  The impact of heparin compounds on cellular inflammatory responses: a construct for future investigation and pharmaceutical development.

Authors:  Essam Elsayed; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2003-02       Impact factor: 2.300

2.  Pretreatment of hypertonic saline can increase endogenous interleukin 10 release to attenuate hepatic ischemia reperfusion injury.

Authors:  Qing-Hong Ke; Shu-Sen Zheng; Ting-Bo Liang; Hai-Yang Xie; Wei-Liang Xia
Journal:  Dig Dis Sci       Date:  2006-11-11       Impact factor: 3.487

3.  The Interface between Inflammation and Coagulation in Cardiovascular Disease.

Authors:  Gabriele Demetz; Ilka Ott
Journal:  Int J Inflam       Date:  2012-02-19

Review 4.  Systemic versus localized coagulation activation contributing to organ failure in critically ill patients.

Authors:  Marcel Levi; Tom van der Poll; Marcus Schultz
Journal:  Semin Immunopathol       Date:  2011-07-30       Impact factor: 9.623

Review 5.  Therapeutic advances in COVID-19.

Authors:  Naoka Murakami; Robert Hayden; Thomas Hills; Hanny Al-Samkari; Jonathan Casey; Lorenzo Del Sorbo; Patrick R Lawler; Meghan E Sise; David E Leaf
Journal:  Nat Rev Nephrol       Date:  2022-10-17       Impact factor: 42.439

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.